| 1.6 |
4.9 |
GO:0090425 |
hepatocyte cell migration(GO:0002194) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
| 1.5 |
6.0 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) cellular response to lipid hydroperoxide(GO:0071449) |
| 1.2 |
7.2 |
GO:0032196 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) transposition(GO:0032196) |
| 1.2 |
18.8 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 1.0 |
3.1 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 1.0 |
2.0 |
GO:2000096 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 1.0 |
2.9 |
GO:0030421 |
defecation(GO:0030421) |
| 0.9 |
4.7 |
GO:0060809 |
mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.9 |
3.6 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.9 |
2.6 |
GO:0042097 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
| 0.8 |
2.5 |
GO:0070671 |
response to interleukin-12(GO:0070671) |
| 0.8 |
2.5 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.8 |
3.3 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.8 |
6.2 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.8 |
3.8 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.7 |
0.7 |
GO:0010574 |
vascular endothelial growth factor production(GO:0010573) regulation of vascular endothelial growth factor production(GO:0010574) |
| 0.7 |
2.8 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.7 |
4.1 |
GO:0051987 |
positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
| 0.7 |
2.0 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.7 |
3.4 |
GO:0038027 |
apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
| 0.7 |
2.0 |
GO:0042320 |
regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) |
| 0.7 |
0.7 |
GO:0072602 |
interleukin-4 secretion(GO:0072602) |
| 0.6 |
3.9 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.6 |
1.9 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 0.6 |
2.5 |
GO:1901894 |
regulation of calcium-transporting ATPase activity(GO:1901894) |
| 0.6 |
2.5 |
GO:2000110 |
negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.6 |
6.8 |
GO:2000741 |
positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.6 |
1.8 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.6 |
2.9 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.6 |
2.9 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
| 0.5 |
0.5 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 0.5 |
1.6 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.5 |
2.7 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.5 |
0.5 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.5 |
2.1 |
GO:1901204 |
regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) |
| 0.5 |
1.5 |
GO:1904956 |
regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
| 0.5 |
1.0 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.5 |
1.0 |
GO:0044837 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.5 |
0.5 |
GO:0032922 |
circadian regulation of gene expression(GO:0032922) |
| 0.5 |
2.4 |
GO:0021856 |
cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
| 0.5 |
1.9 |
GO:1902990 |
mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.5 |
1.4 |
GO:0046121 |
deoxyribonucleoside catabolic process(GO:0046121) |
| 0.5 |
1.4 |
GO:0006404 |
RNA import into nucleus(GO:0006404) |
| 0.5 |
2.3 |
GO:0034441 |
plasma lipoprotein particle oxidation(GO:0034441) |
| 0.5 |
1.4 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.5 |
2.8 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.5 |
1.4 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.4 |
2.2 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.4 |
1.3 |
GO:1902071 |
regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
| 0.4 |
1.8 |
GO:2000911 |
positive regulation of cholesterol import(GO:1904109) positive regulation of sterol import(GO:2000911) |
| 0.4 |
0.4 |
GO:2000564 |
CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
| 0.4 |
5.3 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.4 |
0.4 |
GO:0003134 |
BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) |
| 0.4 |
1.3 |
GO:1904170 |
regulation of bleb assembly(GO:1904170) |
| 0.4 |
2.1 |
GO:0051309 |
female meiosis chromosome separation(GO:0051309) |
| 0.4 |
2.1 |
GO:1902623 |
negative regulation of neutrophil migration(GO:1902623) |
| 0.4 |
0.8 |
GO:0016115 |
terpenoid catabolic process(GO:0016115) |
| 0.4 |
3.8 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.4 |
1.3 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.4 |
0.4 |
GO:0099525 |
presynaptic dense core granule exocytosis(GO:0099525) |
| 0.4 |
1.2 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) odontoblast differentiation(GO:0071895) regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 0.4 |
1.2 |
GO:0070235 |
regulation of activation-induced cell death of T cells(GO:0070235) |
| 0.4 |
0.4 |
GO:0072106 |
regulation of branch elongation involved in ureteric bud branching(GO:0072095) regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
| 0.4 |
4.0 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.4 |
1.2 |
GO:0090324 |
negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.4 |
6.7 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.4 |
1.2 |
GO:0072139 |
glomerular parietal epithelial cell differentiation(GO:0072139) |
| 0.4 |
1.5 |
GO:2000158 |
positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.4 |
1.2 |
GO:0050713 |
negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.4 |
1.5 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.4 |
1.1 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.4 |
1.1 |
GO:0051754 |
meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.4 |
1.9 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.4 |
2.6 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.4 |
0.8 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 0.4 |
1.5 |
GO:0071475 |
cellular hyperosmotic salinity response(GO:0071475) |
| 0.4 |
1.5 |
GO:0019323 |
pentose catabolic process(GO:0019323) |
| 0.4 |
1.1 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 0.4 |
2.6 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.4 |
1.1 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.4 |
0.4 |
GO:0035359 |
negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.4 |
1.1 |
GO:1900275 |
negative regulation of phospholipase C activity(GO:1900275) |
| 0.4 |
0.4 |
GO:0021648 |
vestibulocochlear nerve morphogenesis(GO:0021648) |
| 0.4 |
1.1 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.4 |
5.8 |
GO:2001275 |
positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.4 |
1.8 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.4 |
0.7 |
GO:1902022 |
L-lysine transport(GO:1902022) |
| 0.4 |
0.4 |
GO:0014009 |
glial cell proliferation(GO:0014009) |
| 0.4 |
0.4 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.4 |
0.7 |
GO:0003350 |
pulmonary myocardium development(GO:0003350) |
| 0.3 |
0.3 |
GO:0003406 |
retinal pigment epithelium development(GO:0003406) |
| 0.3 |
1.4 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.3 |
0.7 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 0.3 |
1.0 |
GO:0061386 |
closure of optic fissure(GO:0061386) |
| 0.3 |
1.0 |
GO:1903896 |
positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
| 0.3 |
1.0 |
GO:0021998 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) positive regulation of cardiac ventricle development(GO:1904414) |
| 0.3 |
1.6 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.3 |
0.6 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.3 |
0.9 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.3 |
0.9 |
GO:0021852 |
pyramidal neuron migration(GO:0021852) |
| 0.3 |
2.8 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.3 |
0.6 |
GO:0033087 |
negative regulation of immature T cell proliferation(GO:0033087) |
| 0.3 |
1.8 |
GO:0031587 |
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.3 |
4.6 |
GO:0072189 |
ureter development(GO:0072189) |
| 0.3 |
0.6 |
GO:2000790 |
regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
| 0.3 |
0.9 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.3 |
0.9 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.3 |
1.2 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.3 |
0.3 |
GO:0032615 |
interleukin-12 production(GO:0032615) |
| 0.3 |
2.4 |
GO:0042095 |
interferon-gamma biosynthetic process(GO:0042095) |
| 0.3 |
3.0 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.3 |
3.0 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.3 |
0.9 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.3 |
1.2 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.3 |
0.6 |
GO:0071163 |
DNA replication preinitiation complex assembly(GO:0071163) |
| 0.3 |
2.6 |
GO:1900169 |
regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.3 |
1.7 |
GO:0006570 |
tyrosine metabolic process(GO:0006570) |
| 0.3 |
0.9 |
GO:2000435 |
regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.3 |
0.6 |
GO:1903899 |
positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 0.3 |
2.0 |
GO:0032596 |
protein transport into membrane raft(GO:0032596) |
| 0.3 |
2.9 |
GO:1901386 |
negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.3 |
1.1 |
GO:1904393 |
regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) |
| 0.3 |
1.1 |
GO:1901162 |
serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
| 0.3 |
1.7 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.3 |
2.2 |
GO:0021830 |
interneuron migration from the subpallium to the cortex(GO:0021830) |
| 0.3 |
0.3 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.3 |
2.2 |
GO:0098700 |
neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.3 |
1.1 |
GO:1905065 |
positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
| 0.3 |
0.5 |
GO:0003192 |
mitral valve formation(GO:0003192) |
| 0.3 |
1.9 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 0.3 |
0.3 |
GO:1903463 |
regulation of mitotic cell cycle DNA replication(GO:1903463) |
| 0.3 |
0.3 |
GO:0071033 |
nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
| 0.3 |
1.9 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.3 |
0.8 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.3 |
1.1 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.3 |
0.5 |
GO:0009597 |
detection of virus(GO:0009597) |
| 0.3 |
2.7 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.3 |
10.0 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.3 |
0.5 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.3 |
0.8 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.3 |
1.3 |
GO:0007093 |
mitotic cell cycle checkpoint(GO:0007093) |
| 0.3 |
1.6 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.3 |
1.8 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.3 |
1.0 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.3 |
2.8 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.3 |
0.8 |
GO:0045004 |
DNA replication proofreading(GO:0045004) |
| 0.3 |
2.5 |
GO:1990001 |
inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.3 |
1.5 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.3 |
1.8 |
GO:0072015 |
glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
| 0.3 |
1.3 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.2 |
0.2 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.2 |
1.2 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.2 |
2.7 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.2 |
1.7 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 0.2 |
0.5 |
GO:0046881 |
positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 0.2 |
2.7 |
GO:0060013 |
righting reflex(GO:0060013) |
| 0.2 |
0.2 |
GO:0033194 |
response to hydroperoxide(GO:0033194) |
| 0.2 |
0.5 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.2 |
2.7 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.2 |
1.2 |
GO:1902965 |
regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.2 |
0.7 |
GO:0031204 |
posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.2 |
0.5 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.2 |
0.7 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.2 |
0.2 |
GO:0016093 |
polyprenol metabolic process(GO:0016093) |
| 0.2 |
0.7 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.2 |
0.5 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.2 |
1.0 |
GO:0036493 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.2 |
0.7 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 0.2 |
0.2 |
GO:0006295 |
nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.2 |
0.7 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.2 |
3.9 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.2 |
0.2 |
GO:0035457 |
cellular response to interferon-alpha(GO:0035457) |
| 0.2 |
2.3 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.2 |
2.5 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.2 |
0.5 |
GO:0032212 |
positive regulation of telomere maintenance via telomerase(GO:0032212) |
| 0.2 |
3.9 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.2 |
0.9 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.2 |
0.5 |
GO:0060948 |
cardiac vascular smooth muscle cell development(GO:0060948) |
| 0.2 |
0.7 |
GO:0060382 |
regulation of DNA strand elongation(GO:0060382) |
| 0.2 |
0.7 |
GO:0030862 |
neuroblast division in subventricular zone(GO:0021849) positive regulation of polarized epithelial cell differentiation(GO:0030862) |
| 0.2 |
1.1 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.2 |
0.4 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.2 |
0.2 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.2 |
2.0 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.2 |
0.4 |
GO:0061341 |
non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
| 0.2 |
0.2 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.2 |
2.8 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.2 |
0.2 |
GO:0097527 |
necroptotic signaling pathway(GO:0097527) |
| 0.2 |
2.8 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.2 |
1.7 |
GO:0097475 |
motor neuron migration(GO:0097475) |
| 0.2 |
1.3 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.2 |
2.4 |
GO:0036159 |
inner dynein arm assembly(GO:0036159) |
| 0.2 |
1.3 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.2 |
1.1 |
GO:0072530 |
purine-containing compound transmembrane transport(GO:0072530) |
| 0.2 |
0.9 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.2 |
1.3 |
GO:0045778 |
positive regulation of ossification(GO:0045778) |
| 0.2 |
0.2 |
GO:0048850 |
hypophysis morphogenesis(GO:0048850) |
| 0.2 |
0.4 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
| 0.2 |
2.5 |
GO:1903818 |
positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.2 |
1.0 |
GO:1903347 |
negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.2 |
3.3 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.2 |
0.6 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.2 |
0.2 |
GO:1902730 |
positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.2 |
5.4 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.2 |
1.2 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.2 |
1.0 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.2 |
1.0 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.2 |
0.8 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 0.2 |
0.8 |
GO:0051933 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.2 |
0.4 |
GO:1904659 |
glucose transmembrane transport(GO:1904659) |
| 0.2 |
0.8 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.2 |
1.6 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.2 |
3.2 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.2 |
0.4 |
GO:0023016 |
signal transduction by trans-phosphorylation(GO:0023016) |
| 0.2 |
0.6 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.2 |
0.2 |
GO:0040037 |
negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.2 |
1.0 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.2 |
1.4 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.2 |
1.0 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.2 |
0.6 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) |
| 0.2 |
1.8 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.2 |
0.6 |
GO:1903976 |
negative regulation of glial cell migration(GO:1903976) |
| 0.2 |
2.9 |
GO:1901629 |
regulation of presynaptic membrane organization(GO:1901629) |
| 0.2 |
0.8 |
GO:0090472 |
dibasic protein processing(GO:0090472) |
| 0.2 |
0.2 |
GO:0090004 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.2 |
3.3 |
GO:0048368 |
lateral mesoderm development(GO:0048368) |
| 0.2 |
1.5 |
GO:2001198 |
regulation of dendritic cell differentiation(GO:2001198) |
| 0.2 |
1.7 |
GO:0070874 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.2 |
0.2 |
GO:0002331 |
pre-B cell allelic exclusion(GO:0002331) |
| 0.2 |
1.1 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.2 |
1.5 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
| 0.2 |
0.6 |
GO:0010845 |
positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.2 |
0.2 |
GO:0046060 |
dATP metabolic process(GO:0046060) |
| 0.2 |
0.6 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.2 |
0.9 |
GO:2000258 |
negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
| 0.2 |
1.3 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.2 |
1.1 |
GO:0021683 |
cerebellar granular layer morphogenesis(GO:0021683) |
| 0.2 |
1.7 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.2 |
0.6 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.2 |
0.4 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.2 |
1.5 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.2 |
0.5 |
GO:0046168 |
glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.2 |
1.5 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.2 |
1.5 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.2 |
0.4 |
GO:0061419 |
positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) |
| 0.2 |
0.2 |
GO:1903753 |
negative regulation of p38MAPK cascade(GO:1903753) |
| 0.2 |
1.1 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.2 |
1.1 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.2 |
0.4 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.2 |
0.5 |
GO:2000314 |
negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.2 |
1.6 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.2 |
1.4 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.2 |
0.9 |
GO:2001170 |
negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.2 |
0.5 |
GO:0032229 |
negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.2 |
0.2 |
GO:0033084 |
regulation of immature T cell proliferation in thymus(GO:0033084) |
| 0.2 |
4.2 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.2 |
0.2 |
GO:0031590 |
wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
| 0.2 |
1.7 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.2 |
0.5 |
GO:0044381 |
glucose import in response to insulin stimulus(GO:0044381) |
| 0.2 |
0.2 |
GO:0006590 |
thyroid hormone generation(GO:0006590) |
| 0.2 |
0.3 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.2 |
1.0 |
GO:0030913 |
paranodal junction assembly(GO:0030913) |
| 0.2 |
0.7 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.2 |
1.5 |
GO:0033603 |
positive regulation of dopamine secretion(GO:0033603) |
| 0.2 |
0.2 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.2 |
3.7 |
GO:0097150 |
neuronal stem cell population maintenance(GO:0097150) |
| 0.2 |
0.7 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.2 |
0.3 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.2 |
1.7 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.2 |
0.2 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.2 |
0.5 |
GO:1904996 |
positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.2 |
0.3 |
GO:0060849 |
regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.2 |
0.7 |
GO:2000177 |
regulation of neural precursor cell proliferation(GO:2000177) |
| 0.2 |
0.5 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.2 |
1.3 |
GO:0072615 |
interleukin-17 secretion(GO:0072615) |
| 0.2 |
0.8 |
GO:0043652 |
engulfment of apoptotic cell(GO:0043652) |
| 0.2 |
0.8 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.2 |
2.4 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.2 |
0.5 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.2 |
0.9 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 0.2 |
0.3 |
GO:2001274 |
negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.2 |
1.1 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.2 |
0.9 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.2 |
2.0 |
GO:0006309 |
apoptotic DNA fragmentation(GO:0006309) |
| 0.2 |
2.0 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.2 |
0.6 |
GO:0071481 |
cellular response to X-ray(GO:0071481) |
| 0.2 |
2.8 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.2 |
1.5 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.2 |
3.3 |
GO:0006336 |
DNA replication-independent nucleosome assembly(GO:0006336) |
| 0.2 |
0.3 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.2 |
0.3 |
GO:0051972 |
regulation of telomerase activity(GO:0051972) |
| 0.2 |
0.3 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.2 |
0.8 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.2 |
1.2 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.2 |
0.3 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.2 |
0.9 |
GO:0070447 |
positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
| 0.1 |
0.6 |
GO:0034239 |
regulation of macrophage fusion(GO:0034239) |
| 0.1 |
0.6 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.1 |
0.4 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.1 |
0.6 |
GO:0060623 |
telomeric heterochromatin assembly(GO:0031509) regulation of chromosome condensation(GO:0060623) negative regulation of chromosome condensation(GO:1902340) |
| 0.1 |
1.0 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.1 |
0.7 |
GO:0046477 |
glycosylceramide catabolic process(GO:0046477) |
| 0.1 |
0.7 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.1 |
0.6 |
GO:0046013 |
T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.1 |
2.4 |
GO:0045005 |
DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
| 0.1 |
0.6 |
GO:0031442 |
positive regulation of mRNA 3'-end processing(GO:0031442) |
| 0.1 |
1.3 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.1 |
1.3 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.1 |
0.4 |
GO:1990046 |
positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) stress-induced mitochondrial fusion(GO:1990046) |
| 0.1 |
0.7 |
GO:0042538 |
hyperosmotic salinity response(GO:0042538) |
| 0.1 |
0.6 |
GO:1903061 |
regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
| 0.1 |
0.4 |
GO:0007066 |
female meiosis sister chromatid cohesion(GO:0007066) |
| 0.1 |
0.7 |
GO:0046864 |
retinol transport(GO:0034633) nose morphogenesis(GO:0043585) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) alveolar primary septum development(GO:0061143) |
| 0.1 |
0.3 |
GO:0098914 |
membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.1 |
0.4 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 0.1 |
0.3 |
GO:0045343 |
MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.1 |
0.7 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.1 |
0.4 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.1 |
0.4 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.1 |
0.6 |
GO:0070837 |
dehydroascorbic acid transport(GO:0070837) |
| 0.1 |
1.5 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.1 |
1.4 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.1 |
0.4 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.1 |
0.1 |
GO:0006272 |
leading strand elongation(GO:0006272) |
| 0.1 |
0.8 |
GO:0051660 |
establishment of centrosome localization(GO:0051660) |
| 0.1 |
0.1 |
GO:0003433 |
growth plate cartilage chondrocyte development(GO:0003431) chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.1 |
0.3 |
GO:0002765 |
immune response-inhibiting signal transduction(GO:0002765) |
| 0.1 |
0.4 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.1 |
0.3 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.1 |
1.0 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.1 |
0.4 |
GO:0015938 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 0.1 |
0.1 |
GO:0060693 |
regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.1 |
0.8 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.1 |
0.3 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.1 |
0.8 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.1 |
0.1 |
GO:0021933 |
radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.1 |
0.4 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 |
0.5 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 |
0.7 |
GO:0036344 |
platelet morphogenesis(GO:0036344) |
| 0.1 |
1.5 |
GO:1901407 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.1 |
0.1 |
GO:0072425 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.1 |
1.3 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.1 |
0.3 |
GO:0009814 |
defense response, incompatible interaction(GO:0009814) |
| 0.1 |
0.4 |
GO:0006545 |
glycine biosynthetic process(GO:0006545) |
| 0.1 |
0.9 |
GO:0060349 |
bone morphogenesis(GO:0060349) |
| 0.1 |
0.7 |
GO:0043369 |
CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
| 0.1 |
0.7 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.1 |
0.4 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.1 |
0.1 |
GO:0002586 |
regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.1 |
0.3 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 |
0.4 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 0.1 |
1.3 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.1 |
0.9 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.1 |
0.3 |
GO:0097694 |
establishment of RNA localization to telomere(GO:0097694) |
| 0.1 |
1.1 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.1 |
1.3 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.1 |
1.0 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.1 |
0.4 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 |
0.9 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.1 |
0.4 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 0.1 |
0.7 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.1 |
0.5 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.1 |
1.4 |
GO:0001919 |
regulation of receptor recycling(GO:0001919) |
| 0.1 |
0.4 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.1 |
0.5 |
GO:2000525 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.1 |
0.2 |
GO:1904468 |
negative regulation of tumor necrosis factor secretion(GO:1904468) |
| 0.1 |
0.2 |
GO:0009798 |
axis specification(GO:0009798) |
| 0.1 |
0.7 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.1 |
0.6 |
GO:1990839 |
response to endothelin(GO:1990839) |
| 0.1 |
0.6 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.1 |
0.5 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.1 |
0.4 |
GO:1902741 |
type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.1 |
0.1 |
GO:0051133 |
regulation of NK T cell activation(GO:0051133) |
| 0.1 |
0.1 |
GO:0014834 |
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
| 0.1 |
0.8 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.1 |
0.6 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 |
0.2 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.1 |
1.8 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.1 |
0.2 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.1 |
1.4 |
GO:0071378 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.1 |
0.4 |
GO:0008594 |
photoreceptor cell morphogenesis(GO:0008594) |
| 0.1 |
0.1 |
GO:0070859 |
positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
| 0.1 |
0.4 |
GO:1903077 |
negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
| 0.1 |
0.9 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.1 |
0.6 |
GO:0060576 |
intestinal epithelial cell development(GO:0060576) |
| 0.1 |
0.2 |
GO:0038095 |
Fc-epsilon receptor signaling pathway(GO:0038095) |
| 0.1 |
0.1 |
GO:0009218 |
pyrimidine ribonucleotide metabolic process(GO:0009218) |
| 0.1 |
0.8 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.1 |
0.5 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
0.5 |
GO:0014896 |
muscle hypertrophy(GO:0014896) striated muscle hypertrophy(GO:0014897) |
| 0.1 |
0.3 |
GO:2000973 |
regulation of pro-B cell differentiation(GO:2000973) |
| 0.1 |
0.1 |
GO:0072719 |
cellular response to cisplatin(GO:0072719) |
| 0.1 |
0.8 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.1 |
0.3 |
GO:0051096 |
regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
| 0.1 |
0.7 |
GO:0035878 |
nail development(GO:0035878) |
| 0.1 |
0.3 |
GO:0048687 |
positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
| 0.1 |
0.2 |
GO:1903298 |
regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
| 0.1 |
0.2 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.1 |
4.1 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.1 |
0.8 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.1 |
0.1 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 |
1.0 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.1 |
1.4 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.1 |
0.2 |
GO:2000659 |
regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.1 |
0.3 |
GO:0010508 |
positive regulation of autophagy(GO:0010508) |
| 0.1 |
3.6 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.1 |
0.3 |
GO:0046462 |
monoacylglycerol metabolic process(GO:0046462) |
| 0.1 |
0.1 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.1 |
0.3 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.1 |
0.4 |
GO:0051255 |
spindle midzone assembly(GO:0051255) |
| 0.1 |
0.2 |
GO:0072382 |
minus-end-directed vesicle transport along microtubule(GO:0072382) |
| 0.1 |
0.1 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.1 |
0.1 |
GO:0036257 |
multivesicular body organization(GO:0036257) |
| 0.1 |
0.5 |
GO:0051409 |
response to nitrosative stress(GO:0051409) |
| 0.1 |
0.7 |
GO:0048840 |
otolith development(GO:0048840) |
| 0.1 |
0.3 |
GO:0035989 |
tendon development(GO:0035989) |
| 0.1 |
1.2 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.1 |
0.2 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.1 |
0.5 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.1 |
0.2 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.1 |
0.4 |
GO:2000587 |
negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.1 |
0.2 |
GO:0002423 |
natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) |
| 0.1 |
0.4 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.1 |
1.1 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 |
0.2 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.1 |
0.4 |
GO:1901525 |
negative regulation of macromitophagy(GO:1901525) |
| 0.1 |
0.1 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 |
1.8 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.1 |
0.4 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 |
0.1 |
GO:0045738 |
negative regulation of DNA repair(GO:0045738) |
| 0.1 |
0.4 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 0.1 |
0.5 |
GO:0090267 |
positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.1 |
0.3 |
GO:0070602 |
regulation of chondrocyte development(GO:0061181) regulation of centromeric sister chromatid cohesion(GO:0070602) |
| 0.1 |
1.6 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 |
0.2 |
GO:0006014 |
D-ribose metabolic process(GO:0006014) |
| 0.1 |
0.3 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.1 |
0.2 |
GO:0019805 |
quinolinate biosynthetic process(GO:0019805) |
| 0.1 |
0.4 |
GO:1903288 |
positive regulation of potassium ion import(GO:1903288) |
| 0.1 |
0.4 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.1 |
0.7 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.1 |
0.3 |
GO:0045409 |
negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 0.1 |
1.8 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.1 |
0.7 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.1 |
1.5 |
GO:0030033 |
microvillus assembly(GO:0030033) |
| 0.1 |
0.1 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.1 |
0.5 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.1 |
0.3 |
GO:0060558 |
regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
| 0.1 |
0.3 |
GO:1902170 |
cellular response to reactive nitrogen species(GO:1902170) |
| 0.1 |
1.4 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.1 |
0.2 |
GO:0045086 |
positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.1 |
0.3 |
GO:0044208 |
'de novo' AMP biosynthetic process(GO:0044208) |
| 0.1 |
0.2 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.1 |
0.3 |
GO:0071211 |
protein targeting to vacuole involved in autophagy(GO:0071211) |
| 0.1 |
0.3 |
GO:1902605 |
heterotrimeric G-protein complex assembly(GO:1902605) |
| 0.1 |
0.3 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.1 |
0.1 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.1 |
0.6 |
GO:0017145 |
stem cell division(GO:0017145) |
| 0.1 |
0.3 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 0.1 |
0.8 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 |
0.5 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 0.1 |
1.8 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.1 |
1.2 |
GO:0046036 |
CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
| 0.1 |
1.2 |
GO:0009081 |
branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 |
1.5 |
GO:0044253 |
positive regulation of collagen metabolic process(GO:0010714) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 0.1 |
0.4 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.1 |
2.5 |
GO:0021591 |
ventricular system development(GO:0021591) |
| 0.1 |
0.7 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.1 |
0.1 |
GO:0042421 |
norepinephrine biosynthetic process(GO:0042421) |
| 0.1 |
0.9 |
GO:0032516 |
positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.1 |
0.1 |
GO:0060681 |
branch elongation involved in ureteric bud branching(GO:0060681) |
| 0.1 |
0.5 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.1 |
0.7 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.1 |
0.3 |
GO:0072182 |
regulation of nephron tubule epithelial cell differentiation(GO:0072182) |
| 0.1 |
0.3 |
GO:0014857 |
regulation of skeletal muscle cell proliferation(GO:0014857) |
| 0.1 |
0.3 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.1 |
0.6 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 |
0.5 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.1 |
0.5 |
GO:0015788 |
UDP-N-acetylglucosamine transport(GO:0015788) |
| 0.1 |
0.1 |
GO:0042117 |
monocyte activation(GO:0042117) |
| 0.1 |
0.3 |
GO:0071879 |
positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
| 0.1 |
0.1 |
GO:2001270 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 |
0.2 |
GO:1904504 |
regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.1 |
0.1 |
GO:0002327 |
immature B cell differentiation(GO:0002327) |
| 0.1 |
0.6 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 |
1.0 |
GO:0035999 |
tetrahydrofolate interconversion(GO:0035999) |
| 0.1 |
0.4 |
GO:0051043 |
regulation of membrane protein ectodomain proteolysis(GO:0051043) positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.1 |
0.2 |
GO:0046851 |
negative regulation of bone remodeling(GO:0046851) |
| 0.1 |
0.4 |
GO:0060631 |
regulation of meiosis I(GO:0060631) |
| 0.1 |
0.1 |
GO:0038065 |
collagen-activated signaling pathway(GO:0038065) |
| 0.1 |
0.7 |
GO:0072413 |
signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
| 0.1 |
0.3 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.1 |
0.1 |
GO:0039519 |
modulation by virus of host autophagy(GO:0039519) |
| 0.1 |
0.3 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.1 |
0.2 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.1 |
0.1 |
GO:0072173 |
metanephric tubule morphogenesis(GO:0072173) |
| 0.1 |
1.0 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.1 |
0.3 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.1 |
0.4 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.1 |
2.8 |
GO:0007628 |
adult walking behavior(GO:0007628) |
| 0.1 |
0.6 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.1 |
0.1 |
GO:0002925 |
positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.1 |
1.0 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 0.1 |
1.0 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 |
0.6 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.1 |
0.8 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.1 |
0.1 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
| 0.1 |
0.1 |
GO:0036388 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.1 |
0.2 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.1 |
1.4 |
GO:0042462 |
eye photoreceptor cell development(GO:0042462) |
| 0.1 |
0.2 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.1 |
0.2 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.1 |
0.1 |
GO:0006278 |
RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
| 0.1 |
0.4 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 |
0.2 |
GO:0060912 |
cardiac cell fate specification(GO:0060912) |
| 0.1 |
0.5 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.1 |
2.1 |
GO:0042491 |
auditory receptor cell differentiation(GO:0042491) |
| 0.1 |
0.6 |
GO:0010310 |
regulation of hydrogen peroxide metabolic process(GO:0010310) |
| 0.1 |
0.6 |
GO:1900086 |
positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
| 0.1 |
2.4 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.1 |
0.8 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.1 |
0.4 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.1 |
1.2 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.1 |
0.2 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.1 |
0.2 |
GO:0045006 |
DNA deamination(GO:0045006) |
| 0.1 |
0.2 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.1 |
0.2 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.1 |
0.6 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.1 |
0.5 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 |
0.7 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.1 |
0.1 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.1 |
0.6 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.1 |
0.2 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.1 |
0.5 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.1 |
0.2 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.1 |
0.8 |
GO:0009226 |
nucleotide-sugar biosynthetic process(GO:0009226) |
| 0.1 |
0.3 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.1 |
0.6 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.1 |
0.2 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.1 |
0.2 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.1 |
0.3 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.1 |
0.4 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.1 |
0.8 |
GO:0019184 |
nonribosomal peptide biosynthetic process(GO:0019184) |
| 0.1 |
0.2 |
GO:0007588 |
excretion(GO:0007588) |
| 0.1 |
2.5 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 0.1 |
0.3 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.1 |
1.3 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.1 |
0.4 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.1 |
1.2 |
GO:0010866 |
regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.1 |
0.1 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
| 0.1 |
0.7 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.1 |
0.2 |
GO:1901725 |
regulation of histone deacetylase activity(GO:1901725) |
| 0.1 |
0.4 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.1 |
0.9 |
GO:0097502 |
mannosylation(GO:0097502) |
| 0.1 |
0.4 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.1 |
0.3 |
GO:0036451 |
cap mRNA methylation(GO:0036451) |
| 0.1 |
0.5 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
| 0.1 |
0.1 |
GO:0030497 |
fatty acid elongation(GO:0030497) |
| 0.1 |
0.4 |
GO:0032620 |
interleukin-17 production(GO:0032620) |
| 0.1 |
0.2 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.1 |
0.8 |
GO:0008105 |
asymmetric protein localization(GO:0008105) |
| 0.1 |
0.4 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.1 |
0.4 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.1 |
0.3 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.1 |
0.1 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.1 |
0.3 |
GO:1902592 |
viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
| 0.1 |
0.3 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.1 |
0.3 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.1 |
0.2 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.1 |
0.1 |
GO:0002589 |
regulation of antigen processing and presentation of peptide antigen(GO:0002583) regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
| 0.1 |
0.1 |
GO:1902430 |
negative regulation of beta-amyloid formation(GO:1902430) |
| 0.1 |
0.3 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.1 |
0.5 |
GO:1900364 |
negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.1 |
0.2 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.1 |
0.5 |
GO:0006801 |
superoxide metabolic process(GO:0006801) |
| 0.1 |
0.3 |
GO:1904627 |
response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.1 |
0.8 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 |
0.1 |
GO:0060084 |
synaptic transmission involved in micturition(GO:0060084) |
| 0.1 |
0.3 |
GO:0010635 |
regulation of mitochondrial fusion(GO:0010635) |
| 0.1 |
0.2 |
GO:0019732 |
antifungal humoral response(GO:0019732) antifungal innate immune response(GO:0061760) |
| 0.1 |
1.9 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
| 0.1 |
2.0 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.1 |
0.4 |
GO:0009263 |
deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.1 |
0.1 |
GO:0032627 |
interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
| 0.1 |
0.5 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 |
0.1 |
GO:0016446 |
somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.1 |
0.3 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.1 |
0.2 |
GO:0070849 |
response to epidermal growth factor(GO:0070849) |
| 0.1 |
0.3 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.1 |
0.2 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 |
1.0 |
GO:0072528 |
pyrimidine-containing compound biosynthetic process(GO:0072528) |
| 0.1 |
0.2 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 0.1 |
0.3 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.1 |
0.1 |
GO:0042492 |
gamma-delta T cell differentiation(GO:0042492) regulation of gamma-delta T cell differentiation(GO:0045586) gamma-delta T cell activation(GO:0046629) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.1 |
0.7 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 |
0.4 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.1 |
0.3 |
GO:0034116 |
positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
| 0.1 |
0.2 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.1 |
0.8 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 |
0.2 |
GO:0014866 |
skeletal myofibril assembly(GO:0014866) |
| 0.1 |
4.3 |
GO:0043488 |
regulation of mRNA stability(GO:0043488) |
| 0.1 |
1.6 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 |
0.1 |
GO:1903588 |
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.1 |
1.8 |
GO:0035019 |
somatic stem cell population maintenance(GO:0035019) |
| 0.1 |
0.1 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 0.1 |
0.3 |
GO:1903566 |
positive regulation of protein localization to cilium(GO:1903566) |
| 0.1 |
0.1 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 |
2.9 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.1 |
0.3 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 |
1.2 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.1 |
0.1 |
GO:0032056 |
positive regulation of translation in response to stress(GO:0032056) |
| 0.1 |
0.9 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.1 |
0.4 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.1 |
0.1 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.1 |
0.1 |
GO:0048319 |
axial mesoderm morphogenesis(GO:0048319) |
| 0.1 |
0.3 |
GO:0050651 |
dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.1 |
0.2 |
GO:0035330 |
regulation of hippo signaling(GO:0035330) |
| 0.1 |
0.1 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.1 |
1.0 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.1 |
0.1 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 |
0.1 |
GO:1901985 |
positive regulation of protein acetylation(GO:1901985) |
| 0.1 |
0.9 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.1 |
0.5 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.1 |
1.4 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.1 |
0.1 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.1 |
0.4 |
GO:0042574 |
retinal metabolic process(GO:0042574) |
| 0.1 |
0.7 |
GO:0021859 |
pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
| 0.1 |
0.6 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.1 |
0.1 |
GO:0021932 |
hindbrain radial glia guided cell migration(GO:0021932) |
| 0.1 |
1.6 |
GO:0009268 |
response to pH(GO:0009268) |
| 0.1 |
0.1 |
GO:0086023 |
adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
| 0.1 |
0.1 |
GO:1903335 |
regulation of vacuolar transport(GO:1903335) |
| 0.1 |
0.3 |
GO:0007100 |
mitotic centrosome separation(GO:0007100) |
| 0.1 |
0.1 |
GO:2000675 |
negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.1 |
0.5 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.1 |
0.3 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.1 |
0.4 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 |
0.2 |
GO:0060447 |
bud outgrowth involved in lung branching(GO:0060447) |
| 0.1 |
0.5 |
GO:0045061 |
thymic T cell selection(GO:0045061) |
| 0.1 |
0.3 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.1 |
0.1 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.1 |
0.1 |
GO:0032055 |
negative regulation of translation in response to stress(GO:0032055) |
| 0.1 |
0.2 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.1 |
0.3 |
GO:0090070 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.1 |
0.2 |
GO:0006361 |
transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) transcription initiation from RNA polymerase I promoter(GO:0006361) |
| 0.1 |
0.6 |
GO:0001682 |
tRNA 5'-leader removal(GO:0001682) |
| 0.1 |
0.2 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.1 |
0.4 |
GO:0032288 |
myelin assembly(GO:0032288) |
| 0.1 |
1.1 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
1.1 |
GO:0002066 |
columnar/cuboidal epithelial cell development(GO:0002066) |
| 0.1 |
0.3 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
0.1 |
GO:0033522 |
histone H2A ubiquitination(GO:0033522) |
| 0.1 |
0.1 |
GO:0007063 |
regulation of sister chromatid cohesion(GO:0007063) |
| 0.1 |
0.1 |
GO:1901856 |
negative regulation of cellular respiration(GO:1901856) |
| 0.1 |
0.4 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.1 |
0.1 |
GO:0071850 |
mitotic cell cycle arrest(GO:0071850) |
| 0.1 |
0.3 |
GO:0035701 |
hematopoietic stem cell migration(GO:0035701) |
| 0.1 |
0.6 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 |
0.3 |
GO:0001961 |
positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
| 0.1 |
0.5 |
GO:0009437 |
carnitine metabolic process(GO:0009437) |
| 0.1 |
0.9 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
0.2 |
GO:0050812 |
regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.1 |
0.3 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.1 |
0.2 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.1 |
0.3 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.1 |
0.2 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.1 |
0.2 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.1 |
0.3 |
GO:0043144 |
snoRNA processing(GO:0043144) |
| 0.1 |
0.6 |
GO:0032793 |
positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.1 |
0.4 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.1 |
0.1 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.1 |
0.6 |
GO:0006998 |
nuclear envelope organization(GO:0006998) |
| 0.0 |
0.3 |
GO:0042501 |
serine phosphorylation of STAT protein(GO:0042501) |
| 0.0 |
0.3 |
GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
| 0.0 |
0.1 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 0.0 |
0.2 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.0 |
0.0 |
GO:0001510 |
RNA methylation(GO:0001510) |
| 0.0 |
2.2 |
GO:0000725 |
double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.0 |
0.3 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.0 |
0.1 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.0 |
0.0 |
GO:1900150 |
regulation of defense response to fungus(GO:1900150) |
| 0.0 |
0.0 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.0 |
0.1 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) regulation of vitamin D receptor signaling pathway(GO:0070562) cellular response to vitamin D(GO:0071305) |
| 0.0 |
0.1 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.0 |
0.0 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.0 |
0.1 |
GO:0086053 |
AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.0 |
0.2 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.0 |
0.3 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.0 |
0.3 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.0 |
0.1 |
GO:0061038 |
uterus morphogenesis(GO:0061038) |
| 0.0 |
0.0 |
GO:0006458 |
'de novo' protein folding(GO:0006458) |
| 0.0 |
0.2 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) |
| 0.0 |
0.1 |
GO:0090646 |
mitochondrial tRNA processing(GO:0090646) |
| 0.0 |
0.4 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.0 |
0.1 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.0 |
0.6 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.0 |
0.2 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.0 |
0.1 |
GO:0060601 |
lateral sprouting from an epithelium(GO:0060601) |
| 0.0 |
0.4 |
GO:0042754 |
negative regulation of circadian rhythm(GO:0042754) |
| 0.0 |
0.2 |
GO:0034377 |
plasma lipoprotein particle assembly(GO:0034377) |
| 0.0 |
0.5 |
GO:0032964 |
collagen biosynthetic process(GO:0032964) |
| 0.0 |
0.2 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.0 |
0.1 |
GO:1903406 |
regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
| 0.0 |
0.3 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.0 |
0.2 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.0 |
0.0 |
GO:0000966 |
RNA 5'-end processing(GO:0000966) |
| 0.0 |
0.3 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.0 |
0.1 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.0 |
0.4 |
GO:0003148 |
outflow tract septum morphogenesis(GO:0003148) |
| 0.0 |
0.2 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.0 |
0.1 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.0 |
0.0 |
GO:0090659 |
walking behavior(GO:0090659) |
| 0.0 |
0.2 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.0 |
0.1 |
GO:0061009 |
common bile duct development(GO:0061009) |
| 0.0 |
0.3 |
GO:0045911 |
positive regulation of isotype switching(GO:0045830) positive regulation of DNA recombination(GO:0045911) |
| 0.0 |
0.1 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.0 |
0.0 |
GO:0002154 |
thyroid hormone mediated signaling pathway(GO:0002154) |
| 0.0 |
0.3 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 |
0.1 |
GO:1901673 |
regulation of mitotic spindle assembly(GO:1901673) |
| 0.0 |
0.3 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.0 |
0.0 |
GO:0021756 |
striatum development(GO:0021756) |
| 0.0 |
0.4 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.0 |
0.2 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 |
0.2 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.0 |
0.3 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.0 |
0.1 |
GO:0070162 |
adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
| 0.0 |
0.1 |
GO:1901072 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) glucosamine-containing compound catabolic process(GO:1901072) |
| 0.0 |
0.2 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.0 |
0.1 |
GO:0010838 |
positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.0 |
0.2 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.0 |
0.4 |
GO:0010955 |
negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
| 0.0 |
1.5 |
GO:0007052 |
mitotic spindle organization(GO:0007052) |
| 0.0 |
0.7 |
GO:0051084 |
'de novo' posttranslational protein folding(GO:0051084) |
| 0.0 |
0.1 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.0 |
2.2 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.0 |
0.1 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.0 |
0.1 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.0 |
0.6 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.0 |
0.2 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.0 |
0.2 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 |
0.1 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.0 |
0.0 |
GO:0002551 |
mast cell chemotaxis(GO:0002551) mast cell migration(GO:0097531) |
| 0.0 |
0.2 |
GO:0006777 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.0 |
0.4 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.0 |
0.2 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.0 |
0.5 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.0 |
0.1 |
GO:1903422 |
negative regulation of synaptic vesicle recycling(GO:1903422) |
| 0.0 |
0.7 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 |
0.3 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.0 |
0.0 |
GO:0071034 |
CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.0 |
0.0 |
GO:1990009 |
retinal cell apoptotic process(GO:1990009) |
| 0.0 |
0.1 |
GO:0060215 |
primitive hemopoiesis(GO:0060215) |
| 0.0 |
0.2 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
| 0.0 |
0.2 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.0 |
0.5 |
GO:0070536 |
protein K63-linked deubiquitination(GO:0070536) |
| 0.0 |
0.1 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.0 |
0.1 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.0 |
0.6 |
GO:0014002 |
astrocyte development(GO:0014002) |
| 0.0 |
0.3 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.0 |
0.3 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.0 |
1.4 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.0 |
1.0 |
GO:0006261 |
DNA-dependent DNA replication(GO:0006261) |
| 0.0 |
0.0 |
GO:0070346 |
positive regulation of fat cell proliferation(GO:0070346) |
| 0.0 |
0.7 |
GO:0009409 |
response to cold(GO:0009409) |
| 0.0 |
0.4 |
GO:0035384 |
thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
| 0.0 |
0.5 |
GO:1902751 |
positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.0 |
0.2 |
GO:0034244 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 |
0.1 |
GO:0044783 |
G1 DNA damage checkpoint(GO:0044783) |
| 0.0 |
0.3 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 |
0.4 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.0 |
0.2 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.0 |
0.1 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.0 |
0.2 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.0 |
1.0 |
GO:0010390 |
histone monoubiquitination(GO:0010390) |
| 0.0 |
0.3 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.0 |
0.2 |
GO:0098964 |
dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
| 0.0 |
0.4 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.0 |
0.0 |
GO:0060416 |
response to growth hormone(GO:0060416) |
| 0.0 |
0.0 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.0 |
0.4 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.0 |
0.3 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.0 |
0.3 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.0 |
0.0 |
GO:0032753 |
positive regulation of interleukin-4 production(GO:0032753) |
| 0.0 |
0.1 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.0 |
0.2 |
GO:0061512 |
protein localization to cilium(GO:0061512) |
| 0.0 |
0.4 |
GO:0010831 |
positive regulation of myotube differentiation(GO:0010831) |
| 0.0 |
0.1 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.0 |
0.2 |
GO:0019896 |
axonal transport of mitochondrion(GO:0019896) |
| 0.0 |
0.4 |
GO:0036010 |
protein localization to endosome(GO:0036010) |
| 0.0 |
0.1 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 0.0 |
0.2 |
GO:0045579 |
positive regulation of B cell differentiation(GO:0045579) |
| 0.0 |
0.0 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.0 |
0.1 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.0 |
0.8 |
GO:0006997 |
nucleus organization(GO:0006997) |
| 0.0 |
0.1 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.0 |
0.1 |
GO:0010824 |
regulation of centrosome duplication(GO:0010824) |
| 0.0 |
0.2 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.0 |
0.3 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 |
0.1 |
GO:0010828 |
positive regulation of glucose transport(GO:0010828) |
| 0.0 |
0.3 |
GO:0051647 |
nucleus localization(GO:0051647) |
| 0.0 |
0.2 |
GO:0060351 |
cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.0 |
0.6 |
GO:0007098 |
centrosome cycle(GO:0007098) |
| 0.0 |
0.1 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.0 |
0.4 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.0 |
0.2 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.0 |
0.0 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.0 |
0.3 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.0 |
0.1 |
GO:0002014 |
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 0.0 |
1.4 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.0 |
0.1 |
GO:0032308 |
positive regulation of prostaglandin secretion(GO:0032308) |
| 0.0 |
0.8 |
GO:0070897 |
DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
| 0.0 |
0.1 |
GO:0006868 |
glutamine transport(GO:0006868) |
| 0.0 |
0.0 |
GO:2000399 |
negative regulation of thymocyte aggregation(GO:2000399) |
| 0.0 |
0.2 |
GO:0031123 |
RNA 3'-end processing(GO:0031123) |
| 0.0 |
0.1 |
GO:1902952 |
positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.0 |
0.1 |
GO:0072364 |
regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
| 0.0 |
0.0 |
GO:0002309 |
T cell proliferation involved in immune response(GO:0002309) |
| 0.0 |
0.1 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.0 |
0.1 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.0 |
0.0 |
GO:0048859 |
formation of anatomical boundary(GO:0048859) |
| 0.0 |
0.1 |
GO:0007131 |
reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.0 |
0.1 |
GO:0006538 |
glutamate catabolic process(GO:0006538) |
| 0.0 |
0.2 |
GO:0031573 |
intra-S DNA damage checkpoint(GO:0031573) |
| 0.0 |
0.2 |
GO:0045737 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.0 |
1.4 |
GO:0000380 |
alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.0 |
0.6 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 |
0.2 |
GO:0006851 |
mitochondrial calcium ion transport(GO:0006851) |
| 0.0 |
0.1 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) |
| 0.0 |
0.1 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.0 |
0.2 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
| 0.0 |
0.2 |
GO:0060122 |
inner ear receptor stereocilium organization(GO:0060122) |
| 0.0 |
0.0 |
GO:0036490 |
regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
| 0.0 |
0.1 |
GO:0030432 |
peristalsis(GO:0030432) |
| 0.0 |
0.1 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.0 |
0.2 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 |
0.0 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.0 |
0.1 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.0 |
0.1 |
GO:0071105 |
response to interleukin-11(GO:0071105) |
| 0.0 |
0.2 |
GO:0043949 |
regulation of cAMP-mediated signaling(GO:0043949) |
| 0.0 |
0.1 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 0.0 |
0.3 |
GO:0010837 |
regulation of keratinocyte proliferation(GO:0010837) negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.0 |
0.1 |
GO:0000480 |
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.0 |
0.1 |
GO:1902037 |
negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.0 |
0.1 |
GO:0002489 |
antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
| 0.0 |
0.2 |
GO:1903551 |
regulation of extracellular exosome assembly(GO:1903551) |
| 0.0 |
0.1 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.0 |
0.3 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 |
0.1 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.0 |
0.4 |
GO:0031365 |
N-terminal protein amino acid modification(GO:0031365) |
| 0.0 |
0.1 |
GO:1903003 |
positive regulation of protein deubiquitination(GO:1903003) |
| 0.0 |
0.0 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.0 |
0.1 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.0 |
0.2 |
GO:0015838 |
amino-acid betaine transport(GO:0015838) |
| 0.0 |
0.1 |
GO:0009062 |
fatty acid catabolic process(GO:0009062) |
| 0.0 |
0.5 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.0 |
0.1 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.0 |
0.2 |
GO:0015862 |
uridine transport(GO:0015862) pyrimidine nucleoside transport(GO:0015864) |
| 0.0 |
0.1 |
GO:0071476 |
hypotonic response(GO:0006971) cellular hypotonic response(GO:0071476) |
| 0.0 |
0.4 |
GO:0006152 |
purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
| 0.0 |
0.1 |
GO:0060687 |
regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
| 0.0 |
0.1 |
GO:0006901 |
vesicle coating(GO:0006901) vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.0 |
0.1 |
GO:0048209 |
regulation of vesicle targeting, to, from or within Golgi(GO:0048209) |
| 0.0 |
0.1 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.0 |
0.1 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.0 |
0.0 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.0 |
0.1 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) positive regulation of phospholipid biosynthetic process(GO:0071073) |
| 0.0 |
0.2 |
GO:0016572 |
histone phosphorylation(GO:0016572) |
| 0.0 |
0.1 |
GO:0090305 |
nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
| 0.0 |
0.2 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.0 |
0.1 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 |
0.3 |
GO:0030520 |
intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.0 |
0.1 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.0 |
0.1 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.0 |
0.1 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.0 |
0.1 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 0.0 |
0.1 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.0 |
0.1 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.0 |
0.1 |
GO:0007440 |
foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
| 0.0 |
0.0 |
GO:0060018 |
astrocyte fate commitment(GO:0060018) |
| 0.0 |
0.0 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.0 |
0.0 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.0 |
0.2 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.0 |
0.1 |
GO:0046210 |
regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.0 |
0.1 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.0 |
0.2 |
GO:0044550 |
secondary metabolite biosynthetic process(GO:0044550) |
| 0.0 |
0.1 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.0 |
0.1 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 |
0.2 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.0 |
0.8 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.0 |
0.1 |
GO:0060632 |
regulation of microtubule-based movement(GO:0060632) |
| 0.0 |
0.2 |
GO:0032331 |
negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.0 |
0.1 |
GO:0060768 |
epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
| 0.0 |
0.1 |
GO:0055090 |
acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.0 |
0.1 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.0 |
0.1 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.0 |
0.1 |
GO:0060973 |
cell migration involved in heart development(GO:0060973) |
| 0.0 |
0.1 |
GO:0033173 |
calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.0 |
0.6 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.0 |
0.1 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.0 |
0.1 |
GO:0007289 |
spermatid nucleus differentiation(GO:0007289) |
| 0.0 |
0.2 |
GO:0035646 |
endosome to melanosome transport(GO:0035646) pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.0 |
0.0 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.0 |
0.1 |
GO:0006592 |
ornithine biosynthetic process(GO:0006592) |
| 0.0 |
0.1 |
GO:0043501 |
regulation of skeletal muscle adaptation(GO:0014733) skeletal muscle adaptation(GO:0043501) |
| 0.0 |
0.1 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 |
0.3 |
GO:0061462 |
protein localization to lysosome(GO:0061462) |
| 0.0 |
0.2 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.0 |
0.1 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.0 |
0.2 |
GO:0048747 |
muscle fiber development(GO:0048747) |
| 0.0 |
0.3 |
GO:0097576 |
vacuole fusion(GO:0097576) |
| 0.0 |
0.3 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.0 |
0.4 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.0 |
0.8 |
GO:0000910 |
cytokinesis(GO:0000910) |
| 0.0 |
0.1 |
GO:0003417 |
growth plate cartilage development(GO:0003417) |
| 0.0 |
0.5 |
GO:0070303 |
negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
| 0.0 |
0.0 |
GO:0009125 |
nucleoside monophosphate catabolic process(GO:0009125) |
| 0.0 |
0.2 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.0 |
0.0 |
GO:0019885 |
antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.0 |
0.0 |
GO:0015867 |
ATP transport(GO:0015867) |
| 0.0 |
0.0 |
GO:1990743 |
protein sialylation(GO:1990743) |
| 0.0 |
0.1 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 |
0.0 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
| 0.0 |
0.1 |
GO:0060180 |
female mating behavior(GO:0060180) |
| 0.0 |
0.0 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.0 |
0.2 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.0 |
0.0 |
GO:0002484 |
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.0 |
0.0 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.0 |
0.0 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.0 |
0.1 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.0 |
0.0 |
GO:0001676 |
long-chain fatty acid metabolic process(GO:0001676) |
| 0.0 |
0.0 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.0 |
0.0 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.0 |
0.1 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.0 |
0.0 |
GO:0040018 |
positive regulation of multicellular organism growth(GO:0040018) |
| 0.0 |
0.0 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.0 |
0.0 |
GO:0071542 |
dopaminergic neuron differentiation(GO:0071542) |
| 0.0 |
0.1 |
GO:0006098 |
pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) glucose 6-phosphate metabolic process(GO:0051156) |
| 0.0 |
0.0 |
GO:0090400 |
stress-induced premature senescence(GO:0090400) |
| 0.0 |
0.0 |
GO:0034242 |
negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
| 0.0 |
0.0 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.0 |
0.1 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 |
0.0 |
GO:0043174 |
nucleoside salvage(GO:0043174) |
| 0.0 |
0.0 |
GO:0035696 |
monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 0.0 |
0.0 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.0 |
0.0 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.0 |
0.1 |
GO:0009649 |
entrainment of circadian clock(GO:0009649) |
| 0.0 |
0.0 |
GO:0019731 |
antibacterial humoral response(GO:0019731) |
| 0.0 |
0.0 |
GO:0060126 |
somatotropin secreting cell differentiation(GO:0060126) |
| 0.0 |
0.1 |
GO:0032608 |
interferon-beta production(GO:0032608) |
| 0.0 |
0.7 |
GO:0006892 |
post-Golgi vesicle-mediated transport(GO:0006892) |
| 0.0 |
0.2 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 |
0.0 |
GO:0060279 |
positive regulation of ovulation(GO:0060279) |
| 0.0 |
0.0 |
GO:0033210 |
leptin-mediated signaling pathway(GO:0033210) |
| 0.0 |
0.0 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.0 |
0.1 |
GO:0034389 |
lipid particle organization(GO:0034389) |
